Jason Mellad
Amministratore Delegato presso Start Codon Ltd.
Provenienza dei contatti di primo grado di Jason Mellad
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Start Codon Ltd.
Start Codon Ltd. Investment ManagersFinance Start Codon Ltd (Start Codon) is a venture capital firm founded in 2018 by Jason Mellad and Marek Tyl. The firm is headquartered in London, United Kingdom.
10
| Holding Company | Investment Managers | 10 |
Biomodal Ltd.
Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom.
2
| Holding Company | Miscellaneous Commercial Services | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Jason Mellad tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Director/Board Member | |
ERBA DIAGNOSTICS, INC. | Medical Specialties | Chief Executive Officer | |
Domantis Ltd.
Domantis Ltd. Pharmaceuticals: MajorHealth Technology Domantis Ltd. develops domain antibody therapeutics for treating highly unmet diseases. It enables DABS to serve as building blocks for therapeutics simultaneously directed at more than one disease target. The company was founded in December 2000 and is headquartered Middlesex, the United Kingdom. | Pharmaceuticals: Major | Founder | |
ABCAM PLC | Biotechnology | Founder | |
HENDERSON INTERNATIONAL INCOME TRUST PLC | Investment Trusts/Mutual Funds | Director/Board Member | |
University of Bath | College/University | Undergraduate Degree | |
OCTOPUS AIM VCT PLC | Investment Managers | Director/Board Member | |
University of Oxford | College/University | Undergraduate Degree Doctorate Degree Graduate Degree | |
Babraham Bioscience Technologies Ltd.
Babraham Bioscience Technologies Ltd. Miscellaneous Commercial ServicesCommercial Services Babraham Bioscience Technologies Ltd. provides business research and consulting services. It also offers financial and administrative services to start-up biotech companies. The company was founded in 1996 and is located in Cambridge, UK | Miscellaneous Commercial Services | Director/Board Member | |
The Boston Consulting Group, Inc.
The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of Cambridge | College/University | Doctorate Degree | |
LGV Capital Ltd.
LGV Capital Ltd. Investment ManagersFinance LGV Capital (LGV) is a private equity subsidiary of Legal & General Group Plc (LSE: LGEN), founded in 1986. The firm is headquartered in London. | Investment Managers | Private Equity Investor | |
Queen's University | College/University | Undergraduate Degree | |
University of Leicester | College/University | Doctorate Degree | |
University of Cardiff | College/University | Undergraduate Degree | |
Lumora Ltd.
Lumora Ltd. Electronic Equipment/InstrumentsElectronic Technology Lumora Ltd. provides molecular diagnostic products for the clinical and industrial markets. The company was founded by Laurence Carlo Tisi and James A. H. Murray in 2002 and is headquartered in Cambridge, the United Kingdom. | Electronic Equipment/Instruments | Director/Board Member | |
Oxford Capital Partners LLP
Oxford Capital Partners LLP Investment ManagersFinance Oxford Capital Partners LLP (Oxford Capital Partners) is a venture capital subsidiary of Oxford Capital Partners Holdings Ltd founded in 1999 by Tedd Mott and David Edward Christian Mott. The firm is headquartered in Oxford, United Kingdom. | Investment Managers | Private Equity Analyst | |
Trinity College, Cambridge | College/University | Undergraduate Degree | |
The Bioindustry Association
The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member | |
MRC Laboratory of Molecular Biology
MRC Laboratory of Molecular Biology Miscellaneous Commercial ServicesCommercial Services MRC Laboratory of Molecular Biology provides biological research and development services. it also offers methods for determining the three-dimensional structures of proteins and other macromolecules, the sequencing of DNA and the development of monoclonal antibodies. The company was founded by Max Ferdinand Perutz in 1962 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
FRONTIER DEVELOPMENTS PLC | Recreational Products | Director/Board Member | |
BICYCLE THERAPEUTICS PLC | Biotechnology | Director/Board Member | |
ERBA Diagnostics Mannheim GmbH
ERBA Diagnostics Mannheim GmbH Medical SpecialtiesHealth Technology ERBA Diagnostics Mannheim GmbH manufactures and distributes diagnostic products. It offers solutions in biochemistry, hematology, immunology, critical care, coagulation, urine analysis, electrophoresis, diabetes, microbiology, and molecular diagnosis. The firm also develops, manufactures, and distributes diagnostic reagents, test kits, and instrumentation for autoimmune and infectious diseases and manufactures in-vitro diagnostic kits for use in clinical and hospital laboratories. The company was founded by Suresh Vazirani in 1979 and is headquartered in Mannheim, Germany. | Medical Specialties | Corporate Officer/Principal | |
Buckman Laboratories SARL
Buckman Laboratories SARL Chemicals: Major DiversifiedProcess Industries Buckman Laboratories SARL wholesales chemicals to the paint industry. The firm markets its products under the brand names such as BUCKMAN, BUFLOC, BULAB, BUSAN, BUSPERSE, and BUTROL. The company was founded on December 21, 2007 and is headquartered in Wasquehal, France. | Chemicals: Major Diversified | Director/Board Member | |
Stevenage Bioscience Catalyst
Stevenage Bioscience Catalyst BiotechnologyHealth Technology Stevenage Bioscience Catalyst offers access to equipment and facilities that would otherwise be beyond the reach of small or medium-sized companies. The company is headquartered in Stevenage, the United Kingdom. | Biotechnology | Chairman | |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Ieso Digital Health Ltd.
Ieso Digital Health Ltd. Commercial Printing/FormsCommercial Services Ieso Digital Health Ltd. provides Internet enabled mental health services to health providers, private individuals and businesses. The firm engages in delivering cognitive behavioral therapy. It offers anxiety, bereavement, child and family, depression, drug and alcohol misuse, eating disorder, managing anger, managing pain, obsessive compulsive disorder, panic, phobia, post traumatic stress, relationship, sexual difficulty, sports psychology, stress management, and terminal illness therapy services. The company was founded by Barnaby Perks, Sue Wright and Nadine Field in 2000 and is headquartered in Cambridge, the United Kingdom. | Commercial Printing/Forms | Director/Board Member | |
Camgene Ltd. | Director/Board Member | ||
AbShare Share Plan Ltd. | Director/Board Member | ||
The Evolution Education Trust | Director/Board Member | ||
Congenica Ltd.
Congenica Ltd. BiotechnologyHealth Technology Congenica Ltd. develops genome-based discovery and diagnostic technologies. It uses Sapientia technology platform, which allows genome scale DNA sequence data to be presented within a clinically actionable diagnostic report. The company was founded by Matthew Hurles, Richard Durbin and Philip Beales in 2013 and is headquartered in Hinxton, the United Kingdom. | Biotechnology | Chief Investment Officer | |
Genomics England Ltd.
Genomics England Ltd. Miscellaneous Commercial ServicesCommercial Services Genomics England Ltd. runs and delivers 100,000 genomes project. Its flagship project sequences 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. The company was founded by Jeremy Hunt on July 5, 2013 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Yourgene Health UK Ltd.
Yourgene Health UK Ltd. Medical SpecialtiesHealth Technology Part of Novacyt SAS, Yourgene Health UK Ltd. is a company that engages in developing prenatal diagnostic products for molecular testing laboratories. Yourgene Health UK Ltd. is based in Manchester, UK. Yourgene Health was acquired by ViaLogy Plc on July 04, 2014 for $64.97 million. The British company was founded in 2013. | Medical Specialties | Director/Board Member Director/Board Member | |
YOURGENE HEALTH | Medical Specialties | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
Cambridge Innovation Capital Ltd
Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom. | Investment Managers | Consultant / Advisor Private Equity Investor | |
STORM Therapeutics Ltd.
STORM Therapeutics Ltd. BiotechnologyHealth Technology Storm Therapeutics Ltd. develops small molecule drugs that target RNA-modifying enzymes. It offers research and development of drug molecules for the treatment of specific cancers. The company was founded by Anthony Kouzarides and Eric Miska on April 21, 2015 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
Sense Biodetection Ltd.
Sense Biodetection Ltd. Medical/Nursing ServicesHealth Services Sense Biodetection Ltd. provides molecular diagnostics research services. It focuses on improving healthcare decisions and processes by developing novel, user-centred, handheld tests in the fields of infections and oncology. The company was founded by Harry John Lamble and Ralph Lamble in 2014 and is headquartered in Abingdon, the United Kingdom. | Medical/Nursing Services | Director/Board Member | |
Peregrine 66 Ltd.
Peregrine 66 Ltd. Financial ConglomeratesFinance Peregrine 66 Ltd. is a British investment services company founded in 2017. The private company is based in London, UK. The company provides investment services. | Financial Conglomerates | Director/Board Member | |
Suntail 66 Ltd.
Suntail 66 Ltd. Financial ConglomeratesFinance Suntail 66 Ltd. provides financial intermediary services. The private company is based in London, UK. | Financial Conglomerates | Director/Board Member | |
Babraham Research Campus | Chairman | ||
Proteorex Therapeutics, Inc.
Proteorex Therapeutics, Inc. BiotechnologyHealth Technology Proteorex Therapeutics, Inc. develops novel therapeutics. It is discovering small-molecule drugs to treat diseases with the greatest unmet medical need. The firm’s drug discovery platform integrates a novel synthesis design strategy, machine learning, and patient-derived cell-based screening to unlock targets considered undruggable using existing approaches. The company was founded by Aman Iqbal, Kong T. Nguyen, Robert Batey and Michael Anstey and is headquartered in Toronto, Canada. | Biotechnology | Founder | |
Polyprox Therapeutics Ltd.
Polyprox Therapeutics Ltd. BiotechnologyHealth Technology Polyprox Therapeutics Ltd. operates as biotechnology company which engages in research and development of drugs to treat cancer and neurodegenerative diseases. The company was founded by Laura S. Itzhaki in 2018 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
Apollo Therapeutics LLP
Apollo Therapeutics LLP Financial ConglomeratesFinance Apollo Therapeutics LLP is a British biopharmaceutical company that focuses on translating medical research into medicines. The company is based in Stevenage, UK. The company has a portfolio-model built around a centralized management team of experts in pharmaceutical R&D, manufacturing, commercial strategy, fundraising, and business development. The company's assets are housed in separate wholly-owned subsidiary companies, which incorporate best practices from big pharma and venture capital. The company has a scalable R&D platform for the discovery and development of new medicines, enabled by access to five of the world's leading universities and research institutes. The company was founded in 2015, and the CEO is Richard Mason. | Financial Conglomerates | Director/Board Member | |
Maxion Therapeutics Ltd.
Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Maxion Therapeutics is a British company that specializes in creating first-in-class and protein therapeutics for treating previously untreatable ion channel- and GPCR-driven diseases. The company was founded by John McCafferty, Aneesh Karatt-Vellatt, and is based in London, UK. The company achieves this through their revolutionary KnotBody® technology. John McCafferty has been the CEO since incorporation. | Pharmaceuticals: Major | Chairman | |
Epitopea Ltd.
Epitopea Ltd. Miscellaneous Commercial ServicesCommercial Services Epitopea Ltd. is a British transatlantic biotechnology company that develops immunotherapies to treat cancer by targeting a new class of antigens that are broadly shared between patients with the same cancer indication. The company is based in Cambridge, UK. The company has an extensive proprietary library of cryptigen™ tsas that will drive the development of transformational off the shelf cancer immunotherapies. Epitopea was founded in 2021 by Jonathan David Moore, Claude Perreault, and Pierre Thibault. Jonathan David Moore has been the CEO since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
Apollo Therapeutics Group Ltd.
Apollo Therapeutics Group Ltd. Financial ConglomeratesFinance Apollo Therapeutics Group Ltd. is an investment holding British company. The private company is based in Cambridge, UK. The company was founded in 2021. The CEO is Richard Mason. | Financial Conglomerates | Director/Board Member | |
Horizon Discovery Ltd.
Horizon Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
WORLDWIDE HEALTHCARE TRUST PLC | Investment Trusts/Mutual Funds | Director/Board Member |
Statistiche
Distribuzione geografica
Regno Unito | 43 |
Stati Uniti | 4 |
Canada | 3 |
Germania | 2 |
Francia | 2 |
Settori
Health Technology | 16 |
Finance | 10 |
Commercial Services | 9 |
Consumer Services | 8 |
Miscellaneous | 3 |
Posizioni
Director/Board Member | 46 |
Chairman | 10 |
Corporate Officer/Principal | 9 |
Founder | 6 |
Undergraduate Degree | 5 |
Contatti più connessi
Insiders | |
---|---|
Jonathan Milner | 26 |
Michael Anstey | 14 |
Ian Tomlinson | 11 |
Joanne Parfrey | 9 |
Hayden Jeffreys | 8 |
Joanne Mason | 6 |
Brooke Daniel | 2 |
Robert Gorton | 1 |
Marek Tyl | 1 |
Emma Plowman | 1 |
Jennie Redstall | 1 |
Michael Salako | 1 |
- Borsa valori
- Insiders
- Jason Mellad
- Connessioni Società